21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021
Oct 12, 2023
Age-standardized prevalence rates were higher among women than men, veterans than nonveterans and non-Hispanic whites.
Partnership increases seniors’ access to blood pressure monitoring tool
By
Aaron Dorman
Aug 14, 2023
A new service for blood pressure monitoring will be available to underserved seniors in the Detroit metro area.
Dementia-related deaths have more than tripled since 2000
By
Lois A. Bowers
Mar 15, 2019
“If all four dementia causes were counted together, dementia would have been the third leading cause of death in the United States in 2017,” according to the authors of a new report.
Calcium supplements, mortality tied in seniors with aortic stenosis
Apr 26, 2022
Supplemental calcium with or without vitamin D is linked to increased all-cause and cardiovascular mortality and aortic valve replacement.
New-onset cardiovascular complications common after stroke
Mar 31, 2022
The odds of five-year all-cause mortality were up for stroke patients with acute coronary syndrome, atrial fibrillation/flutter, heart failure or severe ventricular arrhythmias.
Cycling linked to reduced all-cause, cardiovascular mortality in diabetes
Jul 20, 2021
For adults with diabetes, cycling is associated with reduced all-cause and cardiovascular disease (CVD) mortality, according to a study published online July 19 in JAMA Internal Medicine.
Model estimates mortality risk in adults with dementia
Oct 14, 2022
A mortality prediction may help guide treatment and advance care planning for community-dwelling older adults with dementia.
More sitting time tied to mortality, CVD in both rich, poor countries
Jun 17, 2022
The association was seen across countries at all economic levels but particularly among low- and lower-middle-income countries.
2019 to 2020 saw risk-linked deaths from heart disease, stroke up
Mar 29, 2022
The highest risk-associated increases were seen in non-Hispanic Black people followed by Hispanics, non-Hispanic Asian or Pacific Islanders.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.